Variant report
Variant | nsv967779 |
---|---|
Chromosome Location | chr4:103818716-103819396 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CISD2-6 | chr4:103817882-103819394 | NONHSAT097617 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13135358 | chr4:103818724-103818725 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs4699033 | chr4:103818734-103818735 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs13107897 | chr4:103818753-103818754 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs35221199 | chr4:103818830-103818831 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs367931700 | chr4:103818877-103818878 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs13113261 | chr4:103818947-103818948 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs13140754 | chr4:103818969-103818970 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs530422458 | chr4:103818972-103818973 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs13113618 | chr4:103819013-103819014 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs549029377 | chr4:103819037-103819038 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs13140958 | chr4:103819045-103819046 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs13114010 | chr4:103819064-103819065 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs561351224 | chr4:103819069-103819070 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs13113640 | chr4:103819082-103819083 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs115027420 | chr4:103819088-103819089 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs13114179 | chr4:103819089-103819090 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs529579025 | chr4:103819116-103819117 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs548133414 | chr4:103819117-103819118 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs566096216 | chr4:103819153-103819154 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs13114028 | chr4:103819170-103819171 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs540036170 | chr4:103819196-103819197 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs557964117 | chr4:103819208-103819209 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs138236375 | chr4:103819217-103819218 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs537030299 | chr4:103819253-103819254 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs537510665 | chr4:103819282-103819283 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs573718337 | chr4:103819299-103819300 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs190053325 | chr4:103819364-103819365 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
myeloid cancer | 21057493 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:103791200-103834800 | Weak transcription | Ovary | ovary |
2 | chr4:103796400-103819800 | Weak transcription | Stomach Smooth Muscle | stomach |
3 | chr4:103799200-103819400 | Weak transcription | Thymus | Thymus |
4 | chr4:103804800-103819000 | Weak transcription | K562 | blood |
5 | chr4:103817400-103818800 | Weak transcription | HepG2 | liver |
6 | chr4:103818600-103819000 | Enhancers | HSMMtube | muscle |
7 | chr4:103818800-103819400 | Enhancers | HepG2 | liver |
8 | chr4:103819000-103819200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr4:103819000-103819400 | Enhancers | HSMM | muscle |
10 | chr4:103819000-103819400 | Enhancers | K562 | blood |